Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
A fixed-dose combination regimen for HIV-1 treatment. It integrates Lamivudine (CAS 134678-17-4), Tenofovir Disoproxil Fumarate (CAS 205159-90-8), and Nevirapine (CAS 129612-86-2). The co-packaging ensures synchronized dosing to optimize adherence and viral suppression.
Contraindicated in severe hepatic impairment or hypersensitivity. Monitor for lactic acidosis, hepatotoxicity, and opportunistic infections. Store below 25°C in a dry environment away from direct light.